The ENGAGE Study is a global clinical research study assessing the efficacy and safety of an investigational medication, to determine whether it can slow the progression of symptoms in early Alzheimer’s disease. There are currently no approved treatments that delay memory loss and progression of disability in Alzheimer’s disease.

You may be able to take part in the ENGAGE Study if you:

  • are 50–85 years of age
  • are experiencing symptoms that might be related to early

Alzheimer’s disease, such as problems with memory or thinking clearly

  • have someone who can be your study partner to accompany you to certain appointments and provide information about your health.

If you, or someone you know, would like more information about taking part in the ENGAGE study, and helping us to research and advance a potential treatment option for early Alzheimer’s disease, please contact us.



Download Study Brochure


Do you qualify to take part in our studies? Find Out Today

Register to take part

Engage Study